Clinical Trial Update: MaCRA Part B in Nigeria [NA]

View source ↗

Summary

The MaCRA Part B malaria trial in Nigeria, sponsored by PATH, has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malaria

Snippet

Sponsor: PATH | Conditions: Malaria | NA | Status: WITHDRAWN